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Objective 
 
To determine the outcomes of 
pregnancies complicated by 
maternal tuberous sclerosis. 
 
Background 
 
Tuberous sclerosis (TS) is a genetic 
disorder that is inherited in an 
autosomal dominant fashion with 
variable clinical manifestations 
including seizures, mental 
retardation, renal failure and 
pneumothorax. The literature on TS 
in pregnancy is largely based upon 
case reports which have shown a 
43% complication rate including 
oligohydramnios, polyhydramnios, 
IUGR, hemorrhage from ruptured 
renal tumors, PPROM, renal failure, 
placental abruption and perinatal 
demise.   
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Methods 
 
Retrospective chart review of female 
patients with tuberous sclerosis older 
than 18 years treated at our hospital.  
Pregnancy records were then 
obtained after consent consistent 
with IRB approval.  Charts were 
reviewed for pre-pregnancy 
manifestations of tuberous sclerosis, 
pregnancy outcomes, and fetal 
ultrasound manifestations.   
 
Results 
 
Consent forms were mailed to 27 
prospective subjects. Eight forms 
were returned.  Full pregnancy 
records were obtained on 2 subjects 
with partial records from a third 
patient.  Patient #1 had brain tubers 
without epilepsy and multiple 
angiomyolipomas of the kidneys.  
She had normal renal function 
throughout pregnancy.  Her 
pregnancy was complicated by 
oligohydramnios at 38 weeks 
gestation.  Delivery was by cesarean 
section at 39 weeks gestation of a 
2922 gram infant after failure to 
descend.  There were no maternal 
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complications of the pregnancy.  
Patient #2 had brain tubers without 
epilepsy.  She had an uncomplicated 
pregnancy and delivered a 2980 
gram infant at 38 4/7 weeks 
gestation.  Neither of these patients 
had fetal manifestations of tuberous 
sclerosis identified on ultrasound.  
Patient #3 had brain tubers and 
absence seizures.  Her pregnancy 
was complicated by fetal 
rhabdomyomas.  She was lost to 
follow up after 36 weeks of gestation 
but her pregnancy was otherwise 
uncomplicated to this point.  
Nineteen patients did not return 
consent forms. They had been seen 
in our hospital for fetal ultrasound or 
pediatric genetics and continued to 
be followed by their local 
obstetricians.  We extrapolate from 
this that their pregnancies were 
uncomplicated as our university is 
the main referral center for the area.  
We do not have confirmation per 
prenatal records. 
 
Conclusions 
 
We present three cases of maternal 
tuberous sclerosis without major 
complications in pregnancy.  Several 
other patients delivered with a low 
risk obstetrician and we conclude 
from this that maternal tuberous 
sclerosis may not be as high risk for 
pregnancy as previously reported in 
the literature.  This case series can 
aid obstetricians in counseling of 
patients with this rare disorder. 
 
 
